208 related articles for article (PubMed ID: 12916947)
1. Preparation of solid dispersions of nonsteroidal anti-inflammatory drugs with acrylic polymers and studies on mechanisms of drug-polymer interactions.
Pignatello R; Ferro M; Puglisi G
AAPS PharmSciTech; 2002; 3(2):E10. PubMed ID: 12916947
[TBL] [Abstract][Full Text] [Related]
2. Preparation, characterisation and photosensitivity studies of solid dispersions of diflunisal and Eudragit RS100 and RL100.
Pignatello R; Ferro M; De Guidi G; Salemi G; Vandelli MA; Guccione S; Geppi M; Forte C; Puglisi G
Int J Pharm; 2001 May; 218(1-2):27-42. PubMed ID: 11337147
[TBL] [Abstract][Full Text] [Related]
3. Development of extended release coevaporates and coprecipitates of promethazine HCl with acrylic polymers: formulation considerations.
Dahiya S; Pathak K; Sharma R
Chem Pharm Bull (Tokyo); 2008 Apr; 56(4):504-8. PubMed ID: 18379098
[TBL] [Abstract][Full Text] [Related]
4. Flurbiprofen release from Eudragit RS and RL aqueous nanosuspensions: a kinetic study by DSC and dialysis experiments.
Castelli F; Messina C; Sarpietro MG; Pignatello R; Puglisi G
AAPS PharmSciTech; 2002; 3(2):E9. PubMed ID: 12916946
[TBL] [Abstract][Full Text] [Related]
5. Characterization of the mechanism of interaction in ibuprofen-Eudragit RL100 coevaporates.
Pignatello R; Spadaro D; Vandelli MA; Forni F; Puglisi G
Drug Dev Ind Pharm; 2004 Mar; 30(3):277-88. PubMed ID: 15109027
[TBL] [Abstract][Full Text] [Related]
6. Influence of hydroxypropyl-beta-cyclodextrin complexation on piroxicam release from buccoadhesive tablets.
Jug M; Bećirević-Laćan M
Eur J Pharm Sci; 2004 Feb; 21(2-3):251-60. PubMed ID: 14757497
[TBL] [Abstract][Full Text] [Related]
7. Properties of solid dispersions of piroxicam in polyvinylpyrrolidone.
Tantishaiyakul V; Kaewnopparat N; Ingkatawornwong S
Int J Pharm; 1999 Apr; 181(2):143-51. PubMed ID: 10370210
[TBL] [Abstract][Full Text] [Related]
8. Preparation and evaluation of solid dispersions of piroxicam and Eudragit S100 by spherical crystallization technique.
Maghsoodi M; Sadeghpoor F
Drug Dev Ind Pharm; 2010 Aug; 36(8):917-25. PubMed ID: 20180658
[TBL] [Abstract][Full Text] [Related]
9. Dissolution kinetics for coprecipitates of diflunisal with PVP K30.
Rodríguez-Espinosa C; Martínez-Ohárriz MC; Martín C; Goñi MM; Vélaz I; Sánchez M
Eur J Drug Metab Pharmacokinet; 1998; 23(2):109-12. PubMed ID: 9725466
[TBL] [Abstract][Full Text] [Related]
10. Solid dispersions of diflunisal-PVP: polymorphic and amorphous states of the drug.
Martínez-Ohárriz MC; Rodríguez-Espinosa C; Martín C; Goñi MM; Tros-Ilarduya MC; Sánchez M
Drug Dev Ind Pharm; 2002 Jul; 28(6):717-25. PubMed ID: 12149965
[TBL] [Abstract][Full Text] [Related]
11. Preparation and in vitro characterization of a semi-solid dispersion of flurbiprofen with Gelucire 44/14 and Labrasol.
Soliman MS; Khan MA
Pharmazie; 2005 Apr; 60(4):288-93. PubMed ID: 15881610
[TBL] [Abstract][Full Text] [Related]
12. The dissolution enhancement of piroxicam in its physical mixtures and solid dispersion formulations using gluconolactone and glucosamine hydrochloride as potential carriers.
Al-Hamidi H; Obeidat WM; Nokhodchi A
Pharm Dev Technol; 2015 Jan; 20(1):74-83. PubMed ID: 24392858
[TBL] [Abstract][Full Text] [Related]
13. Fast dissolving cyclodextrin complex of piroxicam in solid dispersion part I: influence of β-CD and HPβ-CD on the dissolution rate of piroxicam.
Bouchal F; Skiba M; Chaffai N; Hallouard F; Fatmi S; Lahiani-Skiba M
Int J Pharm; 2015 Jan; 478(2):625-32. PubMed ID: 25522828
[TBL] [Abstract][Full Text] [Related]
14. Bilayer Tablet Formulation of Metformin HCl and Acarbose: A Novel Approach To Control Diabetes.
Tiwari R; Gupta A; Joshi M; Tiwari G
PDA J Pharm Sci Technol; 2014; 68(2):138-52. PubMed ID: 24668601
[TBL] [Abstract][Full Text] [Related]
15. The utilization of drug-polymer interactions for improving the chemical stability of hot-melt extruded solid dispersions.
Guo Z; Lu M; Li Y; Pang H; Lin L; Liu X; Wu C
J Pharm Pharmacol; 2014 Feb; 66(2):285-96. PubMed ID: 24433427
[TBL] [Abstract][Full Text] [Related]
16. Towards improved solubility of poorly water-soluble drugs: cryogenic co-grinding of piroxicam with carrier polymers.
Penkina A; Semjonov K; Hakola M; Vuorinen S; Repo T; Yliruusi J; Aruväli J; Kogermann K; Veski P; Heinämäki J
Drug Dev Ind Pharm; 2016; 42(3):378-88. PubMed ID: 26065533
[TBL] [Abstract][Full Text] [Related]
17. Piroxicam nanoparticles for ocular delivery: physicochemical characterization and implementation in endotoxin-induced uveitis.
Adibkia K; Siahi Shadbad MR; Nokhodchi A; Javadzedeh A; Barzegar-Jalali M; Barar J; Mohammadi G; Omidi Y
J Drug Target; 2007 Jul; 15(6):407-16. PubMed ID: 17613659
[TBL] [Abstract][Full Text] [Related]
18. Molecular properties of flurbiprofen and its solid dispersions with Eudragit RL100 studied by high- and low-resolution solid-state nuclear magnetic resonance.
Mollica G; Geppi M; Pignatello R; Veracini CA
Pharm Res; 2006 Sep; 23(9):2129-40. PubMed ID: 16952004
[TBL] [Abstract][Full Text] [Related]
19. Dissolution, bioavailability and ulcerogenic studies on piroxicam-nicotinamide solid dispersion formulations.
Verma MM; Kumar MT; Balasubramaniam J; Pandit JK
Boll Chim Farm; 2003 Apr; 142(3):119-24. PubMed ID: 12806831
[TBL] [Abstract][Full Text] [Related]
20. Hot melt extrusion (HME) for amorphous solid dispersions: predictive tools for processing and impact of drug-polymer interactions on supersaturation.
Sarode AL; Sandhu H; Shah N; Malick W; Zia H
Eur J Pharm Sci; 2013 Feb; 48(3):371-84. PubMed ID: 23267847
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
